550 related articles for article (PubMed ID: 18361944)
1. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
Tverdek FP; Crank CW; Segreti J
Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Maclayton DO; Hall RG
Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
[TBL] [Abstract][Full Text] [Related]
3. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
4. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
5. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
6. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
Scheinfeld N
J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
[TBL] [Abstract][Full Text] [Related]
7. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.
Lodise TP; McKinnon PS
Pharmacotherapy; 2007 Jul; 27(7):1001-12. PubMed ID: 17594206
[TBL] [Abstract][Full Text] [Related]
8. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
9. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Wenisch C; Laferl H; Szell M; Smolle KH; Grisold A; Bertha G; Krause R
Infection; 2006 Jun; 34(3):148-54. PubMed ID: 16804658
[TBL] [Abstract][Full Text] [Related]
10. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
[TBL] [Abstract][Full Text] [Related]
11. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Rubinstein E; Kollef MH; Nathwani D
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
14. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia--a critical review.
Johnston BL
Semin Respir Infect; 1994 Sep; 9(3):199-206. PubMed ID: 7831542
[TBL] [Abstract][Full Text] [Related]
16. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.
Drew RH
Pharmacotherapy; 2007 Feb; 27(2):227-49. PubMed ID: 17253914
[TBL] [Abstract][Full Text] [Related]
17. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
18. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Culos KA; Cannon JP; Grim SA
Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infections caused by resistant Staphylococcus aureus.
Anstead GM; Quinones-Nazario G; Lewis JS
Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
[TBL] [Abstract][Full Text] [Related]
20. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
